AbbVie
ABBV
#30
Rank
C$603.15 B
Marketcap
C$341.32
Share price
0.39%
Change (1 day)
26.62%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$8.20 Billion

According to AbbVie's latest financial reports the company's current earnings are C$62.81 Billion. In 2025 the company made an earning of C$9.19 Billion, an increase over its 2024 earnings that were of C$5.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$8.20 B-10.77%
2025 C$9.19 B77.53%
2024 C$5.18 B-40.54%
2023 C$8.71 B-53.62%
2022 C$18.78 B3.76%
2021 C$18.10 B282.25%
2020 C$4.73 B-59.67%
2019 C$11.74 B62.13%
2018 C$7.24 B-32.74%
2017 C$10.77 B-1.99%
2016 C$10.99 B18.65%
2015 C$9.26 B180.5%
2014 C$3.30 B-55.57%
2013 C$7.43 B-6.86%
2012 C$7.98 B56.05%
2011 C$5.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.76 B 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.39 B 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.66 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.26 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$14.95 B 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.38 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.44 B 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.95 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.11 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA